NIS study determining prevalence of HER2-low in metastatic breast cancer patients

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
Brazil	Sao Paulo, Brazil
Dominican Republic	Santo Domingo, Dominican Republic
India	Bengaluru, India
India	Delhi, India
India	Hyderabad, India
India	Kochi, India
India	Mumbai, India
India	Varanasi, India
Indonesia	Jakarta, Indonesia
Malaysia	Kaula Lumpur, Malaysia
Malaysia	Subang Jaya, Malaysia
Mexico	Ciudad de Mexico, Mexico
Panama	Panama, Panama
Philippines	Quezon city, Philippines
Singapore	Singapore, Singapore
Thailand	Bangkok, Thailand
Vietnam	Hanoi, Vietnam
Vietnam	Ho Chi Minh, Vietnam
Vietnam	Hue, Vietnam